Auransa
4 known investors
Auransa is a clinical-stage biopharmaceutical company that uses an AI platform to analyze large-scale human disease datasets and gene expression profiles to discover novel cancer therapeutics. The company focuses on precision medicine approaches for liver cancer, cardiotoxicity-safe chemotherapy, and other oncology indications.
AI & Machine LearningBiotechHealthtech
Founders & leadership
PL
Pek LumCo-Founder and CEO
Investors · 4
Frequently asked questions
- What does Auransa do?
- Auransa is a clinical-stage biopharmaceutical company that uses an AI platform to analyze large-scale human disease datasets and gene expression profiles to discover novel cancer therapeutics. The company focuses on precision medicine approaches for liver cancer, cardiotoxicity-safe chemotherapy, and other oncology indications.
- Who founded Auransa?
- Auransa was founded by Pek Lum.
- Who are Auransa's investors?
- Auransa's investors include 11.2 Capital, DCVC (Data Collective), Harmonix Fund, Lux Capital.